Trial Profile
A Phase 1, Open-label, Two-period, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Single-dose Pharmacokinetics Of Pf-06372865 In Healthy Adult Subjects
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 30 Jun 2017
Price :
$35
*
At a glance
- Drugs Darigabat (Primary) ; Itraconazole
- Indications Back pain; Generalised anxiety disorder; Pain
- Focus Pharmacokinetics
- Sponsors Pfizer
- 22 Jul 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by Clinicaltrials.gov record.
- 22 Jun 2015 New trial record